News Focus
News Focus
Followers 11
Posts 747
Boards Moderated 0
Alias Born 11/11/2016

Re: Noob_invester post# 46371

Wednesday, 10/10/2018 8:59:38 PM

Wednesday, October 10, 2018 8:59:38 PM

Post# of 65968
If most of selling is from Canada dilution they got their shares at $0.60. Market cap doesn’t suggest for price to go much lower IMO. I don’t see this getting over $2.50 even in February and possibly $5 a little over a year if we can gain revenue traction in Cali with 4 labs and Mass.

Compared to KS*B market cap of $460M and revenues of $51M. With $10M revenues for EVIO and same multiplier of 9x that gives a $90M market cap and a share price of about $4.50 in about a year from now without more dilution. With $15 million in revenue with current share structure and labs that’d be $6.75 a share.

The question is how much revenue can 4 Cali labs, 1 of 5 mass labs, 4 of 21 Oregon labs, and 60% of a lab by Aurora can bring in once all up and running (waiting on 2 Cali labs and Mass). If that brings in $5m in revenue we are at $2.25 a share. I see that as minimal in a year and wishful thinking of $7 in a little over a year.

So the question right now is how far along are the Cali labs that could be bringing in revenue NOW and were targeted to be open by October 1st?!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y